In this interview, Dr. Gary Pestano and Dr. Prithwish Pal discuss the advantages ddPCR offers in molecular residual disease ...

In recent years, liquid biopsy approaches have emerged as powerful tools in oncology, enabling non‑invasive, real‑time insights into tumor dynamics. Among these technologies, droplet digital PCR ...

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced today that the company’s ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced today that the company’s management will host an informational ...

NEW YORK – Though its business has been somewhat stymied the past few years by long-lasting supply chain struggles followed by an extended biopharma downturn coupled with headwinds challenging the ...

We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Bio-Rad Laboratories, Inc. stands tenth on our list and is currently making waves for launching a new ...

Bio-Rad Laboratories BIO recently announced the launch of four new Droplet Digital PCR (ddPCR) platforms. The newly introduced instruments include the company's QX Continuum ddPCR system, along with ...

This webcast features: Abigail Keller, Senior Scientist, Bio-Rad Laboratories. Adeno-associated viruses (AAVs) are an important vector used to deliver life saving gene therapies to patients. The ...

Gene therapy (introducing genetic material into living cells to fix, replace, enhance, or block a faulty gene) is rapidly gaining traction as a strategy for the treatment of genetic diseases. The ...

Bio-Rad develops products and solutions for the life sciences research and clinical diagnostic markets and enjoys niche market leadership in diagnostic quality controls, antigens, and digital ...

Ultra-rapid digital droplet PCR can measure the levels of tumor cells in a tissue sample in about 15 minutes. (HealthDay News) — Intraoperative ultra-rapid droplet digital polymerase chain reaction ...

Feb 19 (Reuters) - Diagnostics company Bio-Rad (BIO.N), opens new tab has been sued by the California Institute of Technology for allegedly misusing the school's patented technology for analyzing ...